Literature DB >> 15717692

Small cell variant of T-cell prolymphocytic leukemia with a gammadelta immunophenotype.

Shigeo Toyota1, Norihiko Nakamura, Kazuo Dan.   

Abstract

T-cell prolymphocytic leukemia (T-PLL) is a rare postthymic T-cell disorder. The disease is characterized by lymphadenopathy, splenomegaly, skin lesions, a high white blood cell count, and an aggressive clinical course. The small cell variant of T-PLL occurs in approximately 20% of patients. Most T-PLL patients express membrane T-cell receptors (TCR) of the alphabeta phenotype. The diagnosis of small cell variant T-PLL in a 56-year-old woman was based on the findings of abnormal lymphocytosis, immunophenotype, lymphadenopathy, and aggressive clinical behavior. Immunophenotype analysis showed that lymphocytes were positive for CD2, CD3, CD5, CD7, CD8, and TCR gammadelta antigens and negative for CD1a, CD4, and TCR alphabeta antigens. Southern blot analysis revealed rearrangement of the TCR Jgamma and Jdelta-1 genes. A cytogenetic study of peripheral blood showed a normal karyotype. T-PLL with a TCR gammadelta phenotype is very rare. This case was typical T-PLL except for the morphologically small cell type and the lack of the typical chromosome aberration. If cases accumulate in the future, the specific features of the gamma8 type of T-PLL will become clearer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15717692     DOI: 10.1532/ijh97.04129

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  15 in total

1.  Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia.

Authors:  E Matutes; V Brito-Babapulle; J Swansbury; J Ellis; R Morilla; C Dearden; A Sempere; D Catovsky
Journal:  Blood       Date:  1991-12-15       Impact factor: 22.113

Review 2.  Gamma delta T-cell neoplasms: a clinicopathological study of 11 cases.

Authors:  T Saito; Y Matsuno; R Tanosaki; T Watanabe; Y Kobayashi; K Tobinai
Journal:  Ann Oncol       Date:  2002-11       Impact factor: 32.976

3.  Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells.

Authors:  V Gandhi; W Plunkett; S Weller; M Du; M Ayres; C O Rodriguez; P Ramakrishna; G L Rosner; J P Hodge; S O'Brien; M J Keating
Journal:  J Clin Oncol       Date:  2001-04-15       Impact factor: 44.544

4.  T-cell receptor gammadelta T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a postthymic immunophenotype.

Authors:  T Sugimoto; S Imoto; Y Matsuo; K Kojima; M Yasukawa; T Murayama; J Kohfuku; I Mizuno; K Yakushijin; A Sada; R Nishimura; T Koizumi
Journal:  Ann Hematol       Date:  2001-10-13       Impact factor: 3.673

5.  Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of gamma/delta T-cell lymphomas.

Authors:  P Gaulard; P Bourquelot; P Kanavaros; C Haioun; J P Le Couedic; M Divine; M Goossens; E S Zafrani; J P Farcet; F Reyes
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

6.  High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H.

Authors:  C E Dearden; E Matutes; B Cazin; G E Tjønnfjord; A Parreira; B Nomdedeu; P Leoni; F J Clark; D Radia; S M Rassam; T Roques; N Ketterer; V Brito-Babapulle; M J Dyer; D Catovsky
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

7.  Expression of T cell receptor delta chains in benign and malignant T lineage lymphoproliferations.

Authors:  L J Picker; M B Brenner; S Michie; R A Warnke
Journal:  Am J Pathol       Date:  1988-09       Impact factor: 4.307

8.  The morphological spectrum of T-prolymphocytic leukaemia.

Authors:  E Matutes; J Garcia Talavera; M O'Brien; D Catovsky
Journal:  Br J Haematol       Date:  1986-09       Impact factor: 6.998

9.  Immunophenotypic and clinical features of T-cell receptor gammadelta+ T-lineage acute lymphoblastic leukaemia.

Authors:  G Schott; C Sperling; M Schrappe; R Ratei; M Martin; U Meyer; H Riehm; W D Ludwig
Journal:  Br J Haematol       Date:  1998-06       Impact factor: 6.998

10.  Human lymphocytes bearing T cell receptor gamma/delta are phenotypically diverse and evenly distributed throughout the lymphoid system.

Authors:  V Groh; S Porcelli; M Fabbi; L L Lanier; L J Picker; T Anderson; R A Warnke; A K Bhan; J L Strominger; M B Brenner
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

View more
  3 in total

1.  Detection of Epstein-Barr virus in T-cell prolymphocytic leukemia cells in vitro.

Authors:  Ke Lan; Masanao Murakami; Tathagata Choudhuri; Donald E Tsai; Stephen J Schuster; Mariusz A Wasik; Erle S Robertson
Journal:  J Clin Virol       Date:  2008-09-14       Impact factor: 3.168

2.  TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients.

Authors:  Akihiko Yokohama; Akio Saitoh; Hirotaka Nakahashi; Takeki Mitsui; Hiromi Koiso; Yoshitora Kim; Hideki Uchiumi; Takayuki Saitoh; Hiroshi Handa; Takahiro Jimbo; Kayoko Murayama; Tohru Sakura; Hirokazu Murakami; Masamitsu Karasawa; Yoshihisa Nojima; Norifumi Tsukamoto
Journal:  Int J Hematol       Date:  2011-12-23       Impact factor: 2.490

3.  Small Cell Variant of T-Cell Prolymphocytic Leukemia with Acquired Palmoplantar Keratoderma and Cutaneous Infiltration.

Authors:  Buthaina Al-Musalhi; Nancy Shehata; Robin Billick
Journal:  Oman Med J       Date:  2016-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.